This is a summary of the European public assessment report (EPAR) for Nexium Control. It explains how the European Medicines Agency assessed the medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Nexium Control. For practical information about using Nexium Control, patients should read the package leaflet or contact their doctor or pharmacist.
Therapeutic Indication
### Therapeutic indication Nexium Control is indicated for the short-term treatment of reflux symptoms (e.g. heartburn and acid regurgitation) in adults.
Therapeutic Area (MeSH)
ATC Code
A02BC05
ATC Item
esomeprazole
Pharmacotherapeutic Group
Proton pump inhibitors
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| esomeprazole | N/A | 艾司奥美拉唑 |
EMA Name
Nexium Control
Medicine Name
Nexium Control
Aliases
N/ANo risk management plan link.
